ArticleScientific reports2025
Halitosis among users of electronic nicotine delivery systems in a multi-center cross-sectional study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Population-scale characterization of the oral microbiome and associations with metabolic health.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global utilization of Electronic Nicotine Delivery Systems (ENDS) is increasing, with emerging evidence suggesting a potential link between ENDS and halitosis. Nonetheless, direct data addressing this association remains limited. This study aimed to investigate the effects of ENDS usage on halitosis among individuals aged 18-40 in 18 Middle Eastern and North African (MENA) countries. The study was conducted between November 2023 and May 2024, and employed an online self-administered survey that included the validated Halitosis Finding Score (Halfins). The analysis included a total of 7,973 participants categorized by their smoking habits: 71.1% identified as non-users, 12.6% as ENDS users, 10.8% as traditional tobacco users, and 5.5% as dual users. After adjusting for potential confounders, exclusive ENDS users exhibited significantly greater odds of experiencing halitosis (adjusted odds ratio [AOR] = 1.576, 95% CI = 1.367-1.817, p < 0.001), as did dual users (AOR = 1.420, 95% CI = 1.161-1.738, p < 0.001), than non-users did. These findings suggest that the use of ENDS and dual usage may elevate the risk of developing halitosis. However, due to the limitations of the study, it is important to interpret these results with caution. Nonetheless, reducing the use of ENDS could potentially mitigate the risk of halitosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.